目的 介绍一个关键点合并数个局部淋巴管静脉吻合术（Lymphaticovenous anastomosis，LVA）治疗继发性淋巴水肿的淋巴外科谢氏1+X治疗方式。 方法 2023年1月至2024年6月，本组11例因肿瘤根治术合并淋巴结清扫术后产生继发性淋巴水肿患者，肿瘤术后发生淋巴水肿时间为7~190月，平均时间为24.5月，未进行外科手术干预而导致肢体淋巴水肿病程为10~185月，平均为42.6月，上诉患者均采用谢氏1+X手术方式进行治疗。手术后随访时间2~12月，平均6.5月。 结果 分别记录患者手术前后肢体淋巴水肿程度、受累肢体分期、是否继发性蜂窝织炎及其发生时间。本组随访时间点为术前和术后１、３、６、12月。经手术前后各项指标比较，存在显著差异（P<0.05）。 结论 谢氏1+X显微治疗技术是综合治疗继发性淋巴水肿病因和现象的一种有效方案，具有治疗效果好，手术切口少，操作时间短的优势，可以作为继发性淋巴水肿较理想的手术方案使用。
Abstract
Objective To introduce the Xie's 1+X surgical approach, a lymphatic microsurgical technique that combines multiple local lymphaticovenous anastomosis (LVA) at key points for the treatment of secondary lymphedema. Methods From January 2023 to June 2024, a total of 11 patients who developed secondary lymphedema after tumor resection combined with lymphadenectomy were treated using the Xie's 1+X surgical approach. The onset of lymphedema after tumor surgery ranged from 7 to 190 months, with an average of 24.5 months. The duration of lymphedema before surgical intervention ranged from 10 to 185 months, with an average of 42.6 months. All patients underwent treatment using the Xie's 1+X surgical technique. The postoperative follow-up period ranged from 2 to 12 months, with an average of 6.5 months. Results The severity of limb lymphedema, the stage of the affected limb, and the presence and timing of secondary cellulitis were recorded before and after surgery. Follow-up evaluations were conducted at preoperative baseline and at 1, 3, 6, and 12 months postoperatively. There were significant differences in comparative analysis of preoperative and postoperative indicators (P<0.05). Conclusions The Xie's 1+X microsurgical technique is an effective approach for addressing both the underlying causes and manifestations of secondary lymphedema. It offers significant advantages, including high treatment efficacy, minimal surgical incisions, and shorter operative time, making it a promising surgical option for secondary lymphedema management.
关键词
继发性淋巴水肿 /
/
/
淋巴管静脉吻合术 /
/
/
1+X手术方案
Key words
Secondary lymphedema /
/
/
LVA /
/
/
1+X surgical approach
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] 尚翠侠，刘哲，沈剑南，等.乳腺癌术后淋巴水肿患者康复干预中的伦理问题及对此[J]. 中国医学理论理学,2022,35(1):62-65.DOI:10.12026/j.issn.1001-8565.2022.01.11.
[2] Badash I, Gould DJ, Patel KM. Supermicrosurgery: History, applications, training and the future[J]. Front Surg,2018,5:23. DOI: 10.3389/fsurg.2018.00023
[3] 刘长瑞,朱见,郑振华,等.显微外科技术在乳腺癌相关上肢淋巴水肿中的应用[J].中华乳腺病杂志(电子版),2020,14(2):109-111. DOI: 10.3877/cma.j.issn.1674-0807.2020.02.009.
[4] Paskett ED, Dean JA, Oliver JM, et al．Cancer-related lymphedema risk factors, diagnosis, treatment, and impact: a review[J].J Clin Oncol, 2012, 30（30）：3726-3733. DOI: 10.1200/JCO.2012.41.8574.
[5] Qin ES, Bowen MJ, Chen WF. Diagnostic accuracy of bioimpedance spectroscopy in patients with lymphedema: a retrospective cohort analysis[J]. J Plast Reconstr Aesthet Surg, 2018,71(7):1041-1050. DOI: 10.1016/j.bjps.2018.02.012.
[6] Zhang XC, Oliveri JM, Paskett ED. Features, predictors and treatment of breast cancer-related lymphedema[J]. Curr Breast Cancer Rep,2020,12(4):244-254. DOI: 10.1007/s12609-020-00381-0.
[7] Campisi C, Bellini C, Campisi C, et al. Microsurgery for lymphedema: clinical research and long-term results[J]. Microsurgery, 2010, 30(4): 256-260. DOI: 10.1002/micr.20737.
[8] Pusic AL, Cemal Y, Albomoz C, et al. Quality of life among breast cancer patients with lymphedema: a systematic review of patientreported outcome instruments and outcomes[J]. J Cancer Surviv, 2013, 7(1): 83-92. DOI: 10.1007/s11764-012-0247-5.
[9] Granzow, JW, JM Soderberg, AH Kaji, et al. Review of current surgical treatments for lymphedema[J]. Ann Surg Oncol, 2014,21(4):1195-1201. DOI: 10.1245/s10434-014-3518-8.
[10] Maruccia, M, A Pezzolla, E Nacchiero, et al. Efficacy and early results after combining laparoscopic harvest of double gastroepiploic lymph node flap and active physiotherapy for lower extremity lymphedema[J]. Microsurgery, 2019,39(8):679-687. DOI:10.1002/micr.30511.
[11] Maruccia, M, R Elia, P Ciudad, et al. Postmastectomy upper limb lymphedema: Combined vascularized lymph node transfer and scar release with fat graft expedites surgical and patients' related outcomes. A retrospective comparative study[J]. J Plast Reconstr Aesthetic Surg, 2019,72(6):892-901. DOI: 10.1016/j.bjps.2019.01.029.
[12] Mihara, M, H Hara, S Tange, et al. Multisite lymphaticovenular bypass using supermicrosurgery technique for lymphedema management in lower lymphedema cases[J]. Plast Reconstr Surg, 2016,138(1):262-272. DOI: 10.1097/PRS.0000000000002254.
[13] Koshima I, Y Nanba, T Tsutsui, et al. Long-term follow-up after lymphaticovenular anastomosis for lymphedema in the leg[J]. J Reconstr Microsurg, 19 (2003), 209-215. DOI:10.1055/s-2003-40575.
[14] Di Taranto, G, R Elia, V Amorosi, et al. The difference in the caliber of efferent lymphatic vessels among various lymph node flaps[J]. J Surg Oncol, 2018,118(7):1212-1213. DOI:10.1002/jso.25257.
[15] Campisi C. Lymphatic microsurgery: a potent weapon in the war on lymphedema[J]. Lymphology, 1995, 28(3): 110-112.
基金
浙江省卫生厅科技计划项目（2024KY022）
PDF(2991 KB)
京ICP备08002354号-3
